92 related articles for article (PubMed ID: 11041123)
1. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
2. Increase in plasma plasminogen activators inhibitor type 1 concentration after fibrinolytic treatment in patients with acute myocardial infarction is associated with 4G/5G polymorphism of PAI-1 gene.
Mlynarska A; Waszyrowski T; Kasprzak JD
J Thromb Haemost; 2006 Jun; 4(6):1361-6. PubMed ID: 16706983
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction.
Knudsen EC; Seljeflot I; Abdelnoor M; Eritsland J; Mangschau A; Müller C; Arnesen H; Andersen GØ
J Thromb Haemost; 2011 Aug; 9(8):1468-74. PubMed ID: 21624046
[TBL] [Abstract][Full Text] [Related]
4. The role of strict metabolic control by insulin infusion on fibrinolytic profile during an acute coronary event in diabetic patients.
Melidonis A; Stefanidis A; Tournis S; Manoussakis S; Handanis S; Zairis M; Dadiotis L; Foussas S
Clin Cardiol; 2000 Mar; 23(3):160-4. PubMed ID: 10761802
[TBL] [Abstract][Full Text] [Related]
5. Development of a Hypercoagulable-Hypofibrinolytic State Early After Spinal Cord Injury.
Park AJ; Garcia VP; Greiner JJ; Berry AR; Cardenas HL; Wegerson KN; Stauffer B; DeSouza CA
Arch Phys Med Rehabil; 2024 May; 105(5):843-849. PubMed ID: 37977547
[TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women.
Mannucci PM; Bernardinelli L; Foco L; Galli M; Ribichini F; Tubaro M; Peyvandi F
J Thromb Haemost; 2005 Feb; 3(2):280-6. PubMed ID: 15670033
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication.
Christ G; Nikfardjam M; Huber-Beckmann R; Gottsauner-Wolf M; Glogar D; Binder BR; Wojta J; Huber K
J Thromb Haemost; 2005 Feb; 3(2):233-9. PubMed ID: 15670026
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolysis in patients with an abdominal aortic aneurysm with special emphasis on rupture and shock.
Skagius E; Siegbahn A; Bergqvist D; Henriksson AE
J Thromb Haemost; 2008 Jan; 6(1):147-50. PubMed ID: 17922806
[TBL] [Abstract][Full Text] [Related]
9. Changes and significance of the fibrinolytic system following two pulmonary thromboembolisms in a rabbit model.
Liu DC; Duan B; Zhao MN; Wu L; Cao YZ; Liu NB; Xue Z; He ZH; Mi J
J Physiol Pharmacol; 2024 Apr; 75(2):137-144. PubMed ID: 38736261
[TBL] [Abstract][Full Text] [Related]
10. Magnesium sulfate neither potentiates nor inhibits tissue plasminogen activator-induced thrombolysis.
Stewart D; Marder VJ; Starkman S; Saver JL
J Thromb Haemost; 2006 Jul; 4(7):1575-9. PubMed ID: 16839356
[TBL] [Abstract][Full Text] [Related]
11. A proposed reference method for plasminogen activators that enables calculation of enzyme activities in SI units.
Longstaff C; Whitton CM
J Thromb Haemost; 2004 Aug; 2(8):1416-21. PubMed ID: 15304049
[TBL] [Abstract][Full Text] [Related]
12. Variations in fibrinolytic parameters and inhibin-A in pregnancy: related hypertensive disorders.
Sartori MT; Serena A; Saggiorato G; Campei S; Faggian D; Pagnan A; Paternoster DM
J Thromb Haemost; 2008 Feb; 6(2):352-8. PubMed ID: 18021302
[TBL] [Abstract][Full Text] [Related]
13. Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits.
Asselbergs FW; Williams SM; Hebert PR; Coffey CS; Hillege HL; Navis G; Vaughan DE; van Gilst WH; Moore JH
J Thromb Haemost; 2007 Feb; 5(2):313-20. PubMed ID: 17092303
[TBL] [Abstract][Full Text] [Related]
14. Use of Diterpene Ginkgolides Meglumine Injection to Regulate Plasma Levels of PAI-1 and t-PA in Patients With Acute Atherosclerotic Cerebral Infarction.
Chen R; Yan L; Xie P; Tian J; Zhao Y; Liu Y; Xu J; Wang Y; Zhao L
Neurologist; 2022 Nov; 27(6):299-303. PubMed ID: 34855657
[TBL] [Abstract][Full Text] [Related]
15. PAI-1 antagonists: the promise and the peril.
Vaughan DE
Trans Am Clin Climatol Assoc; 2011; 122():312-25. PubMed ID: 21686234
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic proteins of normal pregnancy and pre-eclamptic patients in North West Nigeria.
Oladosu-Olayiwola O; Olawumi H; Babatunde A; Ijaiya M; Durotoye I; Biliaminu S; Ibraheem R
Afr Health Sci; 2018 Sep; 18(3):576-583. PubMed ID: 30602990
[TBL] [Abstract][Full Text] [Related]
17. Plasma t-PA and PAl-1 antigen concentrations in non-insulin dependent diabetic patients: effects of treatment modality on fibrinolysis.
Cho YW; Yang DH; Oh DY; Baick SH; Kim SK; Kim SJ; Hong SY
Korean J Intern Med; 1992 Jul; 7(2):81-6. PubMed ID: 1306076
[TBL] [Abstract][Full Text] [Related]
18. Response of fractional synthesis rate (FSR) of fibrinogen, concentration of D-dimer and fibrinolytic balance to physical activity-based intervention in obese children.
Balagopal P; George D; Sweeten S; Mann KJ; Yarandi H; Mauras N; Vaughan DE
J Thromb Haemost; 2008 Aug; 6(8):1296-303. PubMed ID: 18507721
[TBL] [Abstract][Full Text] [Related]
19. Tissue-type plasminogen activator: a historical perspective and personal account.
Collen D; Lijnen HR
J Thromb Haemost; 2004 Apr; 2(4):541-6. PubMed ID: 15102005
[TBL] [Abstract][Full Text] [Related]
20. FGL1 as a modulator of plasma D-dimer levels: Exome-wide marker analysis of plasma tPA, PAI-1, and D-dimer.
Thibord F; Song C; Pattee J; Rodriguez BAT; Chen MH; O'Donnell CJ; Kleber ME; Delgado GE; Guo X; Yao J; Taylor KD; Ozel AB; Brody JA; McKnight B; Gyorgy B; Simonsick E; Leonard HL; Carrasquilla GD; Guindo-Martinez M; Silveira A; Temprano-Sagrera G; Yanek LR; Becker DM; Mathias RA; Becker LC; Raffield LM; Kilpeläinen TO; Grarup N; Pedersen O; Hansen T; Linneberg A; Hamsten A; Watkins H; Sabater-Lleal M; Nalls MA; Trégouët DA; Morange PE; Psaty BM; Tracy RP; Smith NL; Desch KC; Cushman M; Rotter JI; de Vries PS; Pankratz ND; Folsom AR; Morrison AC; März W; Tang W; Johnson AD
J Thromb Haemost; 2021 Aug; 19(8):2019-2028. PubMed ID: 33876560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
